What they were paid
ACADIA PHARMACEUTICALS Director Compensation Table · the one fiscal year held| Fiscal year | Cash fees | Stock awards | Option awards | Other | Total |
|---|---|---|---|---|---|
| FY2025 | $30,493 | $180,705 | $176,392 | $-1 | $387,589 |
Each year as stated in that year's proxy. A dash means the company reported no figure in that column. Source: ACADIA PHARMACEUTICALS INC DEF 14A filed April 24, 2026, accession 0001193125-26-174163, and prior-year filings. Open the filing on EDGAR.
How this board is paid
company policy · FY2025ACADIA PHARMACEUTICALS pays directors a $150,000 cash retainer.
Committees
FY2025 · as the proxy prints themAudit (Chair)
The rest of the ACADIA PHARMACEUTICALS board
FY2025 · as the company reported each| Director | Role | FY2025 total |
|---|---|---|
| Adora Ndu | Independent Director | $400,294 |
| Catherine Owen Adams | Director | $0 |
| Edmund P. Harrigan | Independent Director | $399,024 |
| Elizabeth A. Garofalo | Independent Director | $392,671 |
| James M. Daly | Independent Director | $393,942 |
| Jonathan Poole | Independent Director | $0 |
| Julian C. Baker | Director | $385,049 |
| Laura A. Brege | Independent Director | $395,212 |
| Stephen R. Biggar | Chair of the Board | $415,542 |
The full ACADIA PHARMACEUTICALS compensation record
free company briefThis page is one director within ACADIA PHARMACEUTICALS's record. The company brief lists every named executive and director, each linking to their own page.
Velarion Pro: every company page, peer tools and exports, one seat